You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
19 June 2026 - Silo Pharma (Nasdaq:SILO), a developmental-stage biopharmaceutical company involved in novel therapeutics and drug delivery systems, announced on Thursday that it has received confirmation that it has regained compliance with the minim...
19 June 2026 - Oncoinvent ASA (Euronext Growth Oslo:ONCIN), a Norway-based clinical-stage radiopharmaceutical company developing innovative treatments for solid cancers, announced on Thursday that its ongoing Phase 2 trial of Radspherin in patients w...
18 June 2026 - Biotechnology company Genentech, a member of the Roche Group (SIX: RO, ROG) (OTCQX: RHHBY), said on Thursday that the US Food and Drug Administration (FDA) has accepted its supplemental Biologics License Application for subcutaneous Lu...
18 June 2026 - US healthcare company Organon (NYSE:OGN) and South Korean biopharmaceutical company Samsung Bioepis Co Ltd announced on Thursday an expansion of their development and commercialisation agreement, granting Organon exclusive commercialis...
18 June 2026 - Precision medicine oncology company IDEAYA Biosciences Inc (NASDAQ:IDYA) announced on Wednesday that its board of directors has elected Yujiro S. Hata as chairman of the board.Hata is currently president and chief executive officer, an...
18 June 2026 - Swedish clinical-stage pharmaceutical company Gesynta Pharma AB announced on Wednesday that 50% of the target of 190 patients have been randomised in its Phase 2 clinical proof-of-concept trial, NOVA.The study is evaluating vipoglansta...